Clinical trial
Influenza Vaccination in Bone Marrow Transplantation
NCT00419224 · The Cleveland Clinic, Other · Completed
Key facts
| NCT number | NCT00419224 |
|---|---|
| Title | Influenza Vaccination in Bone Marrow Transplantation |
| Official title | Immunogenicity of Influenza Vaccination (Flu Vac) in Patients Receiving Nonmyeloablative Allogeneic Peripheral Blood Stem Cell Transplantation (NM Allo PBSCT) Compared to Healthy Controls |
| Lead sponsor | The Cleveland Clinic, Other |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Influenza |
| Intervention type | Biological |
| Interventions | inactivated split-virus influenza vaccine |
| Enrollment | 36 |
| Start date | Oct 1, 2002 |
| Completion | Apr 1, 2003 |
| First posted | Jan 8, 2007 |
| Last update posted | Jan 11, 2007 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: